The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of kinetics of circulating plasma cells before and after induction therapy in newly diagnosed multiple myeloma patients undergoing early transplantation.
 
Rajshekhar Chakraborty
No Relationships to Disclose
 
Eli Muchtar
No Relationships to Disclose
 
Angela Dispenzieri
Consulting or Advisory Role - GlaxoSmithKline (Inst); Prothena (Inst)
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Martha Lacy
No Relationships to Disclose
 
Francis Buadi
No Relationships to Disclose
 
David Dingli
No Relationships to Disclose
 
William J. Hogan
No Relationships to Disclose
 
Shaji Kumar
Honoraria - Kesios Therapuetics; Noxxon Pharma; Skyline Diagnostics
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
 
Dragan Jevremovic
No Relationships to Disclose
 
Suzanne R. Hayman
No Relationships to Disclose
 
Prashant Kapoor
No Relationships to Disclose
 
Nelson Leung
Research Funding - Omeros
 
Morie A. Gertz
Honoraria - Celgene; ION Pharma; Isis Pharmaceuticals; Med Learning Group; Millennium; Novartis; Onyx; Prothena; Research to Practice; Sandoz; Sanofi
Consulting or Advisory Role - Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena